Attached files
| file | filename |
|---|---|
| 10-K/A - FORM 10-K/A - Predictive Oncology Inc. | v330336_10ka.htm |
| EX-31.1 - EXHIBIT 31.1 - Predictive Oncology Inc. | v330336_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Predictive Oncology Inc. | v330336_ex31-2.htm |
Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
AND PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of BioDrain Medical, Inc. (the "Company") for the year ended December 31, 2011 as amended by the Form 10-K/A filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Joshua Kornberg, Chief Executive Officer and, I, Bob Myers, Chief Financial Officer, of the Company, certify, pursuant to § 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1350, that to my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: December 14, 2012
/s/ Joshua Kornberg
Joshua Kornberg
Chief Executive Officer and (Principal Executive Officer)
/s/Bob Myers
Bob Myers
Chief Financial Officer and (Principal Financial Officer)